Summary:
- Researchers have utilized artificial intelligence to identify a novel drug candidate capable of inhibiting senescent cells, which are known to contribute to age-related physiological decline.
- The study demonstrates that this AI-discovered compound effectively slows the aging process in pre-clinical models, highlighting the potential of machine learning to accelerate pharmaceutical discovery in gerontology.